CPSH(CPSH)
CPSH
No analyst ratings available
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E |
|---|---|---|
| Revenue Avg | $35M | $42M |
| Low | $35M | $42M |
| High | $35M | $42M |
| EBITDA Avg | $917,080 | $1M |
| Low | $917,080 | $1M |
| High | $917,080 | $1M |
| EBIT Avg | $219,081 | $264,801 |
| Low | $219,081 | $264,801 |
| High | $219,081 | $264,801 |
| Net Income Avg | $586,975 | $3M |
| Low | $586,975 | $3M |
| High | $586,975 | $3M |
| EPS Avg | $0.04 | $0.18 |
| Low | $0.04 | $0.18 |
| High | $0.04 | $0.18 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 |
|---|---|---|---|---|---|---|
| Revenue Avg | $10M | $10M | $9M | $10M | $12M | $12M |
| Low | $10M | $10M | $9M | $10M | $12M | $12M |
| High | $10M | $10M | $9M | $10M | $12M | $12M |
| EBITDA Avg | $258,502 | $258,240 | $224,944 | $263,483 | $310,150 | $309,888 |
| Low | $258,502 | $258,240 | $224,944 | $263,483 | $310,150 | $309,888 |
| High | $258,502 | $258,240 | $224,944 | $263,483 | $310,150 | $309,888 |
| EBIT Avg | $61,753 | $61,691 | $53,736 | $62,943 | $74,091 | $74,029 |
| Low | $61,753 | $61,691 | $53,736 | $62,943 | $74,091 | $74,029 |
| High | $61,753 | $61,691 | $53,736 | $62,943 | $74,091 | $74,029 |
| Net Income Avg | $359,941 | $539,912 | $539,912 | $719,883 | $899,854 | $1M |
| Low | $359,941 | $539,912 | $539,912 | $719,883 | $899,854 | $1M |
| High | $359,941 | $539,912 | $539,912 | $719,883 | $899,854 | $1M |
| EPS Avg | $0.02 | $0.03 | $0.03 | $0.04 | $0.05 | $0.06 |
| Low | $0.02 | $0.03 | $0.03 | $0.04 | $0.05 | $0.06 |
| High | $0.02 | $0.03 | $0.03 | $0.04 | $0.05 | $0.06 |
| Analysts (Rev / EPS) | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 | 1 / 1 |